Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments

Jeanne S. Sheffield; Flor M. Munoz; Richard H. Beigi; Sonja A. Rasmussen; Kathryn M. Edwards; Jennifer S. Read; R. Phillips Heine; Kevin A. Ault; Geeta K. Swamy; Indira Jevaji; Catherine Y. Spong; Kimberly B. Fortner; Shital M. Patel; Mirjana Nesin

doi:10.1016/j.vaccine.2013.07.031

Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments

Jeanne S. Sheffield, Flor M. Munoz, Richard H. Beigi, Sonja A. Rasmussen, Kathryn M. Edwards, Jennifer S. Read, R. Phillips Heine, Kevin A. Ault, Geeta K. Swamy, Indira Jevaji, Catherine Y. Spong, Kimberly B. Fortner, Shital M. Patel, Mirjana Nesin

Obstetrics & Gynecology

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

The Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, National Institutes of Health organized a series of conferences, "Enrolling Pregnant Women in Clinical Trials of Vaccines and Therapeutics", to discuss enrollment and safety assessments of pregnant women in clinical trials of vaccines. Experts in obstetrics, maternal-fetal medicine, infectious diseases, pediatrics, neonatology, genetics, vaccinology and clinical trial design were charged with identifying normal ranges for vital signs and laboratory assessments in pregnancy. A grading system for adverse events was then developed.

Original language	English (US)
Pages (from-to)	4264-4273
Number of pages	10
Journal	Vaccine
Volume	31
Issue number	40
DOIs	https://doi.org/10.1016/j.vaccine.2013.07.031
State	Published - Sep 13 2013

Keywords

Laboratory assessment
Maternal immunization
Toxicity grading scale

ASJC Scopus subject areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2013.07.031

Cite this

Sheffield, J. S., Munoz, F. M., Beigi, R. H., Rasmussen, S. A., Edwards, K. M., Read, J. S., Heine, R. P., Ault, K. A., Swamy, G. K., Jevaji, I., Spong, C. Y., Fortner, K. B., Patel, S. M., & Nesin, M. (2013). Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments. Vaccine, 31(40), 4264-4273. https://doi.org/10.1016/j.vaccine.2013.07.031

@article{8b6509bd72254802b2f047367516c0af,

title = "Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments",

abstract = "The Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, National Institutes of Health organized a series of conferences, {"}Enrolling Pregnant Women in Clinical Trials of Vaccines and Therapeutics{"}, to discuss enrollment and safety assessments of pregnant women in clinical trials of vaccines. Experts in obstetrics, maternal-fetal medicine, infectious diseases, pediatrics, neonatology, genetics, vaccinology and clinical trial design were charged with identifying normal ranges for vital signs and laboratory assessments in pregnancy. A grading system for adverse events was then developed.",

keywords = "Laboratory assessment, Maternal immunization, Toxicity grading scale",

author = "Sheffield, {Jeanne S.} and Munoz, {Flor M.} and Beigi, {Richard H.} and Rasmussen, {Sonja A.} and Edwards, {Kathryn M.} and Read, {Jennifer S.} and Heine, {R. Phillips} and Ault, {Kevin A.} and Swamy, {Geeta K.} and Indira Jevaji and Spong, {Catherine Y.} and Fortner, {Kimberly B.} and Patel, {Shital M.} and Mirjana Nesin",

year = "2013",

month = sep,

day = "13",

doi = "10.1016/j.vaccine.2013.07.031",

language = "English (US)",

volume = "31",

pages = "4264--4273",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "40",

}

TY - JOUR

T1 - Research on vaccines during pregnancy

T2 - Reference values for vital signs and laboratory assessments

AU - Sheffield, Jeanne S.

AU - Munoz, Flor M.

AU - Beigi, Richard H.

AU - Rasmussen, Sonja A.

AU - Edwards, Kathryn M.

AU - Read, Jennifer S.

AU - Heine, R. Phillips

AU - Ault, Kevin A.

AU - Swamy, Geeta K.

AU - Jevaji, Indira

AU - Spong, Catherine Y.

AU - Fortner, Kimberly B.

AU - Patel, Shital M.

AU - Nesin, Mirjana

PY - 2013/9/13

Y1 - 2013/9/13

N2 - The Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, National Institutes of Health organized a series of conferences, "Enrolling Pregnant Women in Clinical Trials of Vaccines and Therapeutics", to discuss enrollment and safety assessments of pregnant women in clinical trials of vaccines. Experts in obstetrics, maternal-fetal medicine, infectious diseases, pediatrics, neonatology, genetics, vaccinology and clinical trial design were charged with identifying normal ranges for vital signs and laboratory assessments in pregnancy. A grading system for adverse events was then developed.

AB - The Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, National Institutes of Health organized a series of conferences, "Enrolling Pregnant Women in Clinical Trials of Vaccines and Therapeutics", to discuss enrollment and safety assessments of pregnant women in clinical trials of vaccines. Experts in obstetrics, maternal-fetal medicine, infectious diseases, pediatrics, neonatology, genetics, vaccinology and clinical trial design were charged with identifying normal ranges for vital signs and laboratory assessments in pregnancy. A grading system for adverse events was then developed.

KW - Laboratory assessment

KW - Maternal immunization

KW - Toxicity grading scale

UR - http://www.scopus.com/inward/record.url?scp=84882882133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882882133&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2013.07.031

DO - 10.1016/j.vaccine.2013.07.031

M3 - Article

C2 - 23906887

AN - SCOPUS:84882882133

SN - 0264-410X

VL - 31

SP - 4264

EP - 4273

JO - Vaccine

JF - Vaccine

IS - 40

ER -

Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this